Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised Phase II/III Multi-Centre Clinical Trial of Definitive Chemotherapy, With or Without Cetuximab, in Carcinoma of the Oesophagus

NCT00509561 is registered in ClinicalTrials.gov with Wales Cancer Trials Unit as lead sponsor.

NCT NCT00509561
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00509561 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised Phase II/III Multi-Centre Clinical Trial of Definitive Chemotherapy, With or Without Cetuximab, in Carcinoma of the Oesophagus
Lead sponsor
Wales Cancer Trials Unit
Phase
Phase 2/3
Overall status
Unknown status
Start date
February 29, 2008
Completion date
Not reported
Enrollment
259 (actual)
Sites
55

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal cancer